2,059 Shares in Plexus Corp. (NASDAQ:PLXS) Purchased by Olympiad Research LP

Olympiad Research LP purchased a new position in shares of Plexus Corp. (NASDAQ:PLXSFree Report) during the 4th quarter, HoldingsChannel reports. The institutional investor purchased 2,059 shares of the technology company’s stock, valued at approximately $322,000.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Disciplined Growth Investors Inc. MN boosted its holdings in Plexus by 2.8% during the third quarter. Disciplined Growth Investors Inc. MN now owns 2,168,512 shares of the technology company’s stock worth $296,457,000 after purchasing an additional 59,465 shares during the last quarter. Pacer Advisors Inc. purchased a new position in Plexus during the fourth quarter worth about $107,489,000. Geode Capital Management LLC raised its position in Plexus by 0.8% in the third quarter. Geode Capital Management LLC now owns 653,759 shares of the technology company’s stock worth $89,392,000 after acquiring an additional 4,926 shares during the period. Charles Schwab Investment Management Inc. raised its position in Plexus by 0.7% in the third quarter. Charles Schwab Investment Management Inc. now owns 421,903 shares of the technology company’s stock worth $57,678,000 after acquiring an additional 2,886 shares during the period. Finally, Victory Capital Management Inc. raised its position in Plexus by 3.9% in the third quarter. Victory Capital Management Inc. now owns 200,186 shares of the technology company’s stock worth $27,367,000 after acquiring an additional 7,483 shares during the period. 94.45% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several brokerages have commented on PLXS. Needham & Company LLC lifted their price objective on shares of Plexus from $162.00 to $172.00 and gave the stock a “buy” rating in a research report on Friday, January 24th. Benchmark reaffirmed a “buy” rating and issued a $165.00 price objective on shares of Plexus in a research report on Wednesday, January 22nd. StockNews.com raised shares of Plexus from a “hold” rating to a “buy” rating in a research report on Monday, November 18th. Finally, Stifel Nicolaus began coverage on shares of Plexus in a research report on Tuesday, February 4th. They issued a “hold” rating and a $152.00 price objective on the stock. Two equities research analysts have rated the stock with a hold rating and three have given a buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $163.00.

Read Our Latest Stock Report on PLXS

Insider Activity

In other news, CEO Todd P. Kelsey sold 1,500 shares of Plexus stock in a transaction on Thursday, January 2nd. The stock was sold at an average price of $156.39, for a total value of $234,585.00. Following the completion of the transaction, the chief executive officer now directly owns 74,271 shares in the company, valued at approximately $11,615,241.69. The trade was a 1.98 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Randy J. Martinez sold 887 shares of Plexus stock in a transaction on Tuesday, February 18th. The shares were sold at an average price of $140.52, for a total value of $124,641.24. Following the completion of the transaction, the director now owns 4,831 shares of the company’s stock, valued at approximately $678,852.12. This trade represents a 15.51 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 18,208 shares of company stock worth $2,613,240. 1.76% of the stock is owned by corporate insiders.

Plexus Stock Performance

Shares of PLXS stock opened at $137.34 on Friday. The stock has a market capitalization of $3.71 billion, a P/E ratio of 31.87 and a beta of 0.89. Plexus Corp. has a 12 month low of $90.18 and a 12 month high of $172.89. The company has a current ratio of 1.53, a quick ratio of 0.70 and a debt-to-equity ratio of 0.07. The firm’s 50 day moving average is $153.12 and its 200 day moving average is $145.05.

Plexus (NASDAQ:PLXSGet Free Report) last announced its quarterly earnings results on Wednesday, January 22nd. The technology company reported $1.49 earnings per share for the quarter, missing the consensus estimate of $1.59 by ($0.10). Plexus had a net margin of 3.03% and a return on equity of 10.36%. On average, sell-side analysts anticipate that Plexus Corp. will post 5.9 earnings per share for the current year.

About Plexus

(Free Report)

Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.

See Also

Want to see what other hedge funds are holding PLXS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Plexus Corp. (NASDAQ:PLXSFree Report).

Institutional Ownership by Quarter for Plexus (NASDAQ:PLXS)

Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.